Breast Cancer Treatment ImportanceBreast cancer will be diagnosed in 12% of women in the United States over the course of their lifetimes and more than 250 000 new cases of breast cancer were diagnosed in the United States in 2017. This review focuses on current approaches and evolving strate...
Today, in spite of significant advances in cancer treatment has been made, however, breast cancer is still remains as one of the main health problem and considered as a top biomedical investigation urgency. The present study reviewed the common conventional chemotherapy agents and also some ...
Breast cancer is the most frequent malignancy in women worldwide and is curable in ~70–80% of patients with early-stage, non-metastatic disease. Advanced breast cancer with distant organ metastases is considered incurable with currently available therap
Breast Cancer Research and Treatment provides the surgeon, radiotherapist, medical oncologist, endocrinologist, epidemiologist, immunologist or cell biologist investigating problems in breast cancer a single forum for communication. The journal creates a "market place" for breast cancer topics which cuts ac...
Cancer Treatment Reviews. 2018, 62, 50–60 [56]. 2.4. Poly (ADP-Ribose) Polymerase (PARP) Inhibitors The polyadenosine diphosphate-ribose polymerase also called poly (ADP-ribose) polymerase (PARP) is a superfamily of 18 proteins that effect all the molecular events that leads to recovery ...
Stage 0 Breast Cancer Treatment Some experts consider stage 0 the earliest stage of breast cancer. Others think of it as a sort of precancer stage. Stage I Breast Cancer Treatment In this stage, the cancer either hasn't spread beyond the breast or has spread in a very small amount to a...
Cancer Treatment ReviewsPossinger K, Wagner H, Langecker P, Wilmanns W: Treatment toxicity reduction: breast cancer. Cancer Treat Rev 1987, 14:263-274.Possinger K, Wagner H, Langecker P, Wilmanns W: Treatment toxicity reduction: breast cancer. Cancer Treat Rev 1987, 14 : 263-274. Pub...
The key role of immune-checkpoint inhibitors in the treatment of TNBC is being defined and a plethora of ongoing trials testing different combination approaches will provide additional insights to improve the efficacy of immunotherapy. The application of a breast cancer immunogram describing the TNBC ...
This paper reviews the theoretical background for the use of progestins in advanced breast cancer and the clinical experience obtained from 13 major studies. The average rate of response is about 30%, with somewhat higher rates when the dominant site of disease is localized to soft tissue and ...
This article reviews staging of breast cancer and treatment protocols for the disease, then examines several different types of breast cancer. Each type is described in terms of its mammographic, sonographic and histologic appearance, along with its treatment and prognosis. The author concludes with ...